Bonnie Bengtsson, Gustaf Pak, Juan Vaz, Linnea Widman, Hannes Hagström
{"title":"肝癌根治性治疗后肿瘤复发的风险。","authors":"Bonnie Bengtsson, Gustaf Pak, Juan Vaz, Linnea Widman, Hannes Hagström","doi":"10.1080/00365521.2025.2565334","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Tumour recurrence remains a major obstacle to long-term survival following curative treatment for hepatocellular carcinoma (HCC). This cohort study aimed to identify clinical and tumour-related factors associated with HCC recurrence.</p><p><strong>Methods: </strong>A total of 346 patients treated with curative intent at Karolinska University Hospital between 2010 and 2017 were analysed. Patients were stratified by treatment modality and recurrence status.</p><p><strong>Results: </strong>Resection (adjusted hazard ratio [aHR] = 6.0, 95%CI = 2.5-14.5) and ablation (aHR = 10.3, 95%CI = 4.5-23.7) were independently associated with higher recurrence compared to liver transplantation. Alpha-fetoprotein (AFP) levels ≥100 µg/L (aHR = 3.1, 95%CI = 2.0-4.7) and active smoking at baseline (aHR = 1.7, 95%CI = 1.1-2.6) were significantly associated with recurrence.</p><p><strong>Conclusion: </strong>These findings highlight the relevance of AFP in recurrence prediction and surveillance planning and points out that smoking history can be of importance although this needs to be further validated.</p>","PeriodicalId":21461,"journal":{"name":"Scandinavian Journal of Gastroenterology","volume":" ","pages":"1-4"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk of tumour recurrence following curative treatment of hepatocellular carcinoma.\",\"authors\":\"Bonnie Bengtsson, Gustaf Pak, Juan Vaz, Linnea Widman, Hannes Hagström\",\"doi\":\"10.1080/00365521.2025.2565334\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Tumour recurrence remains a major obstacle to long-term survival following curative treatment for hepatocellular carcinoma (HCC). This cohort study aimed to identify clinical and tumour-related factors associated with HCC recurrence.</p><p><strong>Methods: </strong>A total of 346 patients treated with curative intent at Karolinska University Hospital between 2010 and 2017 were analysed. Patients were stratified by treatment modality and recurrence status.</p><p><strong>Results: </strong>Resection (adjusted hazard ratio [aHR] = 6.0, 95%CI = 2.5-14.5) and ablation (aHR = 10.3, 95%CI = 4.5-23.7) were independently associated with higher recurrence compared to liver transplantation. Alpha-fetoprotein (AFP) levels ≥100 µg/L (aHR = 3.1, 95%CI = 2.0-4.7) and active smoking at baseline (aHR = 1.7, 95%CI = 1.1-2.6) were significantly associated with recurrence.</p><p><strong>Conclusion: </strong>These findings highlight the relevance of AFP in recurrence prediction and surveillance planning and points out that smoking history can be of importance although this needs to be further validated.</p>\",\"PeriodicalId\":21461,\"journal\":{\"name\":\"Scandinavian Journal of Gastroenterology\",\"volume\":\" \",\"pages\":\"1-4\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/00365521.2025.2565334\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00365521.2025.2565334","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Risk of tumour recurrence following curative treatment of hepatocellular carcinoma.
Objectives: Tumour recurrence remains a major obstacle to long-term survival following curative treatment for hepatocellular carcinoma (HCC). This cohort study aimed to identify clinical and tumour-related factors associated with HCC recurrence.
Methods: A total of 346 patients treated with curative intent at Karolinska University Hospital between 2010 and 2017 were analysed. Patients were stratified by treatment modality and recurrence status.
Results: Resection (adjusted hazard ratio [aHR] = 6.0, 95%CI = 2.5-14.5) and ablation (aHR = 10.3, 95%CI = 4.5-23.7) were independently associated with higher recurrence compared to liver transplantation. Alpha-fetoprotein (AFP) levels ≥100 µg/L (aHR = 3.1, 95%CI = 2.0-4.7) and active smoking at baseline (aHR = 1.7, 95%CI = 1.1-2.6) were significantly associated with recurrence.
Conclusion: These findings highlight the relevance of AFP in recurrence prediction and surveillance planning and points out that smoking history can be of importance although this needs to be further validated.
期刊介绍：
The Scandinavian Journal of Gastroenterology is one of the most important journals for international medical research in gastroenterology and hepatology with international contributors, Editorial Board, and distribution
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
